- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Elad Anter
Total 210 results
-
Elad AnterBiosense Webster, Inc.CompletedAtrial Fibrillation | Atrial FlutterUnited States
-
Antev Ltd.CompletedHealthyUnited Kingdom
-
Antea FoundationCompletedPain | Cancer | Breakthrough Pain | Pain Due to Certain Specified Procedures | Terminal DiseaseItaly
-
Mohamed Elsibai AnterCompleted
-
Elan PharmaceuticalsTerminatedMultiple Sclerosis
-
Antev Ltd.Completed
-
Elan PharmaceuticalsCompleted
-
Elan PharmaceuticalsTerminatedMultiple SclerosisUnited States, Canada
-
Elan PharmaceuticalsCompletedMigraine HeadacheUnited States
-
Elan PharmaceuticalsCompletedStroke | Multiple Sclerosis | Muscle Spasticity | Spinal Cord InjuryUnited States
-
Elan PharmaceuticalsTerminatedBipolar Disorders
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Belgium, Mexico, Poland, Romania, Saudi Arabia, Ukraine
-
BiogenElan PharmaceuticalsCompleted
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Spain
-
BiogenElan PharmaceuticalsCompletedMultiple SclerosisUnited States
-
BiogenElan PharmaceuticalsCompletedSafety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingUnited States, Germany, Austria, Belgium, France, Israel, Italy
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-Remitting
-
Elda University HospitalRecruiting
-
BiogenElan PharmaceuticalsCompleted
-
BiogenElan PharmaceuticalsTerminatedRheumatoid ArthritisUnited States, Canada
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States
-
BiogenElan PharmaceuticalsWithdrawn
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis | Pregnancy | Crohn's Disease | Prenatal ExposureUnited States
-
BiogenElan PharmaceuticalsCompleted
-
BiogenElan PharmaceuticalsCompletedMultiple SclerosisUnited States, Puerto Rico
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom, United States, Canada, Belgium, Czech Republic, France, Germany, Netherlands
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States, United Kingdom
-
BiogenElan PharmaceuticalsTerminated
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States, Canada
-
BiogenElan PharmaceuticalsCompletedMultiple SclerosisUnited States
-
BiogenElan PharmaceuticalsTerminatedLeukoencephalopathy, Progressive Multifocal | Immune Reconstitution Inflammatory SyndromeGermany, United States
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
BiogenElan PharmaceuticalsTerminatedProgressive Multifocal LeukoencephalopathyUnited States, Brazil, Italy, Spain, Germany
-
Stanford UniversityElan PharmaceuticalsCompletedCerebral PalsyUnited States
-
Inter-American Development BankCompleted
-
ELA Medical, Inc.Approved for marketing
-
ELA Medical, Inc.Completed
-
ELA Medical, Inc.CompletedSudden Cardiac DeathUnited States
-
CPL AssociatesElan PharmaceuticalsCompleted
-
Abanoub emad fayezNot yet recruiting
-
Vlad RadulescuCompletedCancer | Infertility | Rheumatologic Disorder | Hematologic DisorderUnited States
-
OPKO Health, Inc.Elan PharmaceuticalsCompletedDown SyndromeUnited States
-
OPKO Health, Inc.Elan PharmaceuticalsCompletedAlzheimer's DiseaseUnited States, Canada, Spain, United Kingdom
-
OPKO Health, Inc.Elan PharmaceuticalsTerminatedBipolar 1 DisorderUnited States, Bulgaria, Canada, Czechia, France, Poland, Romania, Spain, Turkey
-
emad gamal ismailUnknown
-
GenfitNaturalpha; SGS Aster S.A.S.CompletedCardiovascular Diseases | Metabolic Diseases | Diabetes Mellitus, Type 2 | Type 2 Diabetes | Dyslipidemia | ObeseFrance